Interleukin Profiling in Atopic Dermatitis and Chronic Nodular Prurigo

Area of Science:

• Immunology
• Dermatology
• Molecular Biology

Background:

• Atopic dermatitis (AD) and chronic nodular prurigo (CNPG) are characterized by severe pruritus and skin lesions.
• Th2 cells and innate lymphoid cells type 2 (ILC2) drive inflammation via cytokines like IL-4 and IL-13, making them therapeutic targets.
• Interleukin-13 (IL-13) exerts its effects through the IL-13 receptor system, including IL-13Rα1 and the decoy receptor IL-13Rα2.

Purpose of the Study:

• To investigate the gene expression of key interleukins (IL-4, IL-13, IL-31) and their receptors in skin biopsies from patients with AD, CNPG, and healthy controls (HC).
• To explore the correlation between the expression of these molecules and clinical symptoms of pruritus and hyperkinesis.

Main Methods:

• Ex vivo analysis of skin biopsies from 17 AD patients, 14 CNPG patients, and 10 HC.
• Quantitative gene expression analysis of IL-4, IL-13, IL-31, IL-13RA1, and IL-13RA2.

Main Results:

• AD skin showed significantly upregulated IL-4, IL-13, and IL-13RA1 compared to HC.
• CNPG skin did not exhibit increased IL-13 expression but showed altered IL-13RA2 patterns.
• IL-13RA2 was markedly increased in AD compared to HC and CNPG, correlating positively with itch intensity and hyperkinesis.

Conclusions:

• IL-4, IL-13, and IL-13RA1 play a significant role in the pathogenesis of pruritus in both AD and CNPG.
• The increased IL-13RA2 in AD may counteract IL-13 signaling, potentially mitigating itch, while its absence in CNPG might exacerbate symptoms.
• These findings highlight distinct interleukin-receptor dynamics in different pruritus phenotypes, suggesting potential biomarker and therapeutic targets.